BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22703374)

  • 1. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program.
    Wallasch TM; Angeli A; Kropp P
    Headache; 2012; 52(7):1094-105. PubMed ID: 22703374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of an intensive multidisciplinary headache treatment program.
    Gunreben-Stempfle B; Griessinger N; Lang E; Muehlhans B; Sittl R; Ulrich K
    Headache; 2009 Jul; 49(7):990-1000. PubMed ID: 19473281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
    Wang SJ; Fuh JL; Lu SR; Juang KD
    Neurology; 2007 Feb; 68(8):591-6. PubMed ID: 17182975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of biofeedback in the treatment of migraine and tension type headaches.
    Mullally WJ; Hall K; Goldstein R
    Pain Physician; 2009; 12(6):1005-11. PubMed ID: 19935987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive/tertiary care for headache: a 6-month outcome study.
    Saper JR; Lake AE; Madden SF; Kreeger C
    Headache; 1999 Apr; 39(4):249-63. PubMed ID: 15613222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of a group-based acceptance and commitment additive therapy on rehabilitation of female outpatients with chronic headache: preliminary findings reducing 3 dimensions of headache impact.
    Mo'tamedi H; Rezaiemaram P; Tavallaie A
    Headache; 2012; 52(7):1106-19. PubMed ID: 22712503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
    Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life, depression, and anxiety 6 months after inpatient withdrawal in patients with medication overuse headache: an observational study.
    Zebenholzer K; Thamer M; Wöber C
    Clin J Pain; 2012 May; 28(4):284-90. PubMed ID: 22001669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and anxiety: effect on the migraine-obesity relationship.
    Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
    Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache and anxiety-depressive disorder comorbidity: the HADAS study.
    Beghi E; Allais G; Cortelli P; D'Amico D; De Simone R; d'Onofrio F; Genco S; Manzoni GC; Moschiano F; Tonini MC; Torelli P; Quartaroli M; Roncolato M; Salvi S; Bussone G
    Neurol Sci; 2007 May; 28 Suppl 2():S217-9. PubMed ID: 17508174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated care for migraine and chronic tension-type headaches: A prospective observational study.
    Cramer H; Hehlke M; Vasmer J; Rampp T; Anheyer D; Saha FJ; Paul A; Lauche R; Dobos G
    Complement Ther Clin Pract; 2019 Aug; 36():1-6. PubMed ID: 31383425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-resistant medication overuse headache can be cured.
    Munksgaard SB; Bendtsen L; Jensen RH
    Headache; 2012; 52(7):1120-9. PubMed ID: 22724425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxation treatment of adolescent headache sufferers: results from a school-based replication series.
    Larsson B; Carlsson J; Fichtel A; Melin L
    Headache; 2005 Jun; 45(6):692-704. PubMed ID: 15953302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive inpatient treatment of refractory chronic daily headache.
    Lake AE; Saper JR; Hamel RL
    Headache; 2009 Apr; 49(4):555-62. PubMed ID: 19245391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of migraine and tension-type headache: a population-based follow-up study.
    Lyngberg AC; Rasmussen BK; Jørgensen T; Jensen R
    Neurology; 2005 Aug; 65(4):580-5. PubMed ID: 16116119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache characteristics and chronification of migraine and tension-type headache: A population-based study.
    Ashina S; Lyngberg A; Jensen R
    Cephalalgia; 2010 Aug; 30(8):943-52. PubMed ID: 20656705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.